![Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses from Teva - Pharmacy In Focus Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses from Teva - Pharmacy In Focus](http://pharmacyinfocus.co.uk/wp-content/uploads/2017/01/Accord-logo.jpg)
Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses from Teva - Pharmacy In Focus
![Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times](https://img.etimg.com/thumb/msid-54696609,width-1200,height-900,imgsize-173278,overlay-economictimes/photo.jpg)
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times
![Teva anuncia resultados provisionales prometedores de su estudio PEARL sobre el impacto de AJOVY® (fremanezumab) | Business Wire Teva anuncia resultados provisionales prometedores de su estudio PEARL sobre el impacto de AJOVY® (fremanezumab) | Business Wire](https://mms.businesswire.com/media/20220624005275/es/739014/23/teva_RGB_JPEG.jpg)
Teva anuncia resultados provisionales prometedores de su estudio PEARL sobre el impacto de AJOVY® (fremanezumab) | Business Wire
![Pharmaceutical Science student awarded €9,000 Philip Kelly Teva Excellence Scholarship | News | Waterford Institute of Technology Pharmaceutical Science student awarded €9,000 Philip Kelly Teva Excellence Scholarship | News | Waterford Institute of Technology](https://www.wit.ie/images/made/images/uploads/News_Pics/Teva_scholarship_group_FINAL_web_380_253.jpg)